Biohit Oyj

Board/Management Information • Jun 6, 2024

Disclosure 447680

Biohit Oyj - Other information disclosed according to the rules of the Exchange

Constitutive meeting of Biohit Oyj's Board of Directors

Biohit Oyj, Other information disclosed according to the rules of the Exchange, June 6, 2024 at 11:00 am local time (EEST)

Biohit Oyj’s Board of Directors has in its meeting on June 5, 2024 elected LL.D, Lic (BA) Vesa Silaskivi as the Chairman of the Board of Directors.

Silaskivi is an experienced board professional and thus a valuable contributor to the company’s growth.

Additional information:

CEO Jussi Hahtela, Biohit Oyj

tel. +358 9 773 861

investor.relations@biohit.fi

www.biohithealthcare.com

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com